Search Results - "Koezuka, Ryo"

Familial Hypercholesterolemia and Lipoprotein Apheresis by Makino, Hisashi, Koezuka, Ryo, Tamanaha, Tamiko, Ogura, Masatsune, Matsuki, Kota, Hosoda, Kiminori, Harada-Shiba, Mariko

“…Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is…”
Get full text

Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia by Harada-Shiba, Mariko, Koezuka, Ryo, Makino, Hisashi, Ogura, Masatsune

Get full text

Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes by Omura-Ohata, Yoko, Son, Cheol, Makino, Hisashi, Koezuka, Ryo, Tochiya, Mayu, Tamanaha, Tamiko, Kishimoto, Ichiro, Hosoda, Kiminori

“…Visceral fat area (VFA) is a good surrogate marker of obesity-related disorders, such as hypertension, dyslipidemia and glucose intolerance. Although…”
Get full text

Hypocholesterolemia is a risk factor for reduced systemic vascular resistance reactivity during hemodialysis by Matsuo, Miki, Kojima, Shiori, Arisato, Tetsuya, Matsubara, Masaki, Koezuka, Ryo, Kishida, Masatsugu, Ogawa, Koji, Inoue, Hiroshi, Yoshihara, Fumiki

“…Intradialytic hypotension (IDH) is associated with high mortality. Peripheral vascular resistance and circulating blood volume are important factors in IDH;…”
Get full text

Effect of tofogliflozin on cardiac and vascular endothelial function in patients with type 2 diabetes and heart diseases: A pilot study by Tochiya, Mayu, Makino, Hisashi, Tamanaha, Tamiko, Matsuo, Miki, Hishida, Ai, Koezuka, Ryo, Ohata, Yoko, Tomita, Tsutomu, Son, Choel, Miyamoto, Yoshihiro, Yasuda, Satoshi, Hosoda, Kiminori

“…Recent studies have shown that sodium–glucose cotransporter 2 inhibitors decrease the risk of heart failure in patients with type 2 diabetes. However, the…”
Get full text

A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol by Matsubara, Masaki, Makino, Hisashi, Washida, Kazuo, Matsuo, Miki, Koezuka, Ryo, Ohata, Yoko, Tamanaha, Tamiko, Honda-Kohmo, Kyoko, Noguchi, Michio, Tomita, Tsutomu, Son, Cheol, Nakai, Michikazu, Nishimura, Kunihiro, Miyamoto, Yoshihiro, Ihara, Masafumi, Hosoda, Kiminori

“…Introduction Although the risk of dementia among patients with type 2 diabetes mellitus (T2DM) is double that of those without T2DM, the mechanism remains to…”
Get full text

High Stroke Volume Variation Is an Independent Predictor for Decreased Blood Pressure During Hemodialysis by Yoshihara, Fumiki, Kishida, Masatsugu, Ogawa, Koji, Nishigaki, Takayuki, Nakasaki, Hironori, Ishizuka, Azusa, Koezuka, Ryo, Matsuo, Miki, Hayashi, Teruyuki, Nakamura, Satoko

“…It currently remains unclear whether stroke volume variation (SVV) before hemodialysis (HD) is an independent predictor of decreased blood pressure (BP) during…”
Get full text

Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study by Makino, Hisashi, Matsuo, Miki, Hishida, Ai, Koezuka, Ryo, Tochiya, Mayu, Ohata, Yoko, Tamanaha, Tamiko, Son, Cheol, Miyamoto, Yoshihiro, Hosoda, Kiminori

“…Background Dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used for the treatment of type 2 diabetes and have been previously shown to prevent diabetic…”
Get full text

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes by Tochiya, Mayu, Makino, Hisashi, Tamanaha, Tamiko, Omura‐Ohata, Yoko, Matsubara, Masaki, Koezuka, Ryo, Noguchi, Michio, Tomita, Tsutomu, Asaumi, Yasuhide, Miyamoto, Yoshihiro, Yasuda, Satoshi, Hosoda, Kiminori

“…Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction…”
Get full text

Hypocholesterolemia is a risk factor for reduced systemic vascular resistance reactivity during hemodialysis by Matsuo, Miki, Kojima, Shiori, Arisato, Tetsuya, Matsubara, Masaki, Koezuka, Ryo, Kishida, Masatsugu, Ogawa, Koji, Inoue, Hiroshi, Yoshihara, Fumiki

Get full text

Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial by Kataoka, Yu, Kitahara, Satoshi, Funabashi, Sayaka, Makino, Hisashi, Matsubara, Masaki, Matsuo, Miki, Omura-Ohata, Yoko, Koezuka, Ryo, Tochiya, Mayu, Tamanaha, Tamiko, Tomita, Tsutomu, Honda-Kohmo, Kyoko, Noguchi, Michio, Murai, Kota, Sawada, Kenichiro, Iwai, Takamasa, Matama, Hideo, Honda, Satoshi, Fujino, Masashi, Nakao, Kazuhiro, Yoneda, Shuichi, Takagi, Kensuke, Otsuka, Fumiyuki, Asaumi, Yasuhide, Hosoda, Kiminori, Nicholls, Stephen J., Yasuda, Satoshi, Noguchi, Teruo

“…Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease…”
Get full text

697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients by Makino, Hisashi, Oya, Aiko, Shima, Taiki, Tsuda, Natsumi, Koezuka, Ryo, Tochiya, Mayu, Ohata, Yoko, Tamanaha, Tamiko, Noguchi, Michio, Hosoda, Kiminori

“…Background and Aim: Acceptance and commitment therapy (ACT) is a psychological intervention using uses mindfulness strategies and acceptance along with…”
Get full text

Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia by Harada-Shiba, Mariko, Koezuka, Ryo, Makino, Hisashi, Ogura, Masatsune

Get full text

The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial by Kataoka, Yu, Kitahara, Satoshi, Funabashi, Sayaka, Makino, Hisashi, Matsubara, Masaki, Matsuo, Miki, Omura-Ohata, Yoko, Koezuka, Ryo, Tochiya, Mayu, Tamanaha, Tamiko, Tomita, Tsutomu, Honda-Kohmo, Kyoko, Noguchi, Michio, Maruki, Maki, Kanai, Emi, Murai, Kota, Iwai, Takamasa, Sawada, Kenichiro, Matama, Hideo, Honda, Satoshi, Fujino, Masashi, Yoneda, Syuichi, Takagi, Kensuke, Otsuka, Fumiyuki, Asaumi, Yasuhide, Hosoda, Kiminori, Nicholls, Stephen J., Yasuda, Satoshi, Noguchi, Teruo

“…Continuous glucose monitoring (CGM) improves glycemic fluctuation and reduces hypoglycemic risk. Whether CGM-guided glycemic control favorably modulates…”
Get full text

Familial Hypercholesterolemia and Lipoprotein Apheresis by Makino, Hisashi, Koezuka, Ryo, Tamanaha, Tamiko, Ogura, Masatsune, Matsuki, Kota, Hosoda, Kiminori, Harada-Shiba, Mariko

“…Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is…”
Get full text

Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study) by Tamanaha, Tamiko, Makino, Hisashi, Son, Cheol, Koezuka, Ryo, Tochiya, Mayu, Omura-Ohata, Yoko, Takekawa, Tatsuya, Matsubara, Masaki, Noguchi, Michio, Tomita, Tsutomu, Honda-Kohmo, Kyoko, Matsuo, Miki, Tateishi, Emi, Fukuda, Tetsuya, Miyamoto, Yoshihiro, Yasuda, Satoshi, Hosoda, Kiminori

“…Introduction In patients with type 2 diabetes (T2D), treatment with sodium–glucose cotransporter-2 (SGLT2) inhibitors has been shown to reduce hospital…”
Get full text

DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial by Yoshihara, Fumiki, Imazu, Miki, Sakuma, Ichiro, Hiroi, Yukio, Okazaki, Osamu, Ishiguro, Chizuru, Izumi, Chisato, Noguchi, Teruo, Shiraiwa, Toshihiko, Tomonaga, Osamu, Kobayashi, Koichi, Takihata, Masahiro, Yumoto, Kazuhiko, Takase, Hiroyuki, Himi, Toshiharu, Murakami, Tsutomu, Wagatsuma, Kenji, Hiramatsu, Takeyuki, Akabame, Satoshi, Hata, Shiro, Asakura, Masanori, Kawabata, Takanori, Omae, Katsuhiro, Ito, Shin, Yoshihara, Fumiki, Imazu, Miki, Kawabata, Takanori, Omae, Katsuhiro, Izumi, Chisato, Kanzaki, Hideaki, Okada, Atsushi, Amano, Masashi, Moriuchi, Kenji, Ito, Shin, Tamanaha, Tamiko, Noguchi, Michio, Arisato, Tetsuya, Noguchi, Teruo, Kataoka, Yu, Asaumi, Yasuhide, Fujino, Masashi, Otsuka, Fumiyuki, Yoneda, Shuichi, Honda, Satoshi, Miura, Hiroyuki, Hiroi, Yukio, Okazaki, Toru, Nakagawa, Takashi, Kubota, Shuji, Torii, Shunsuke, Yamamoto, Jumpei, Miyake, Wataru, Nagai, Ran, Ishiwata, Mai, Nishioka, Norio, Maeno, Yoshifumi, Shiraiwa, Yuka, Fujii, Kenshi, Iwakura, Katsuomi, Okamura, Atsunori, Hirao, Yuko, Tanaka, Koji, Iwamoto, Mutsumi, Okada, Masato, Tanaka, Kota, Watanabe, Satoshi, Kashiyama, Toshikazu, Tomonaga, Osamu, Kobayashi, Koichi, Ishiki, Ryoji, Yamamoto, Dai, Ito, Tadahiro, Takihata, Masahiro, Yumoto, Kazuhiko, Fukuzawa, Tomoyuki, Hayashi, Kazusa, Hyodo, Yusuke, Ikari, Yuji, Ohno, Yohei, Sakama, Susumu, Nakamura, Norihito, Torii, Sho, Ijichi, Takeshi, Wagatsuma, Kenji, Nii, Hideo, Uchida, Yasuto, Hiramatsu, Takeyuki, Takada, Yasunobu, Akabame, Satoshi, Kitajima, Hiroki, Kato, Yukinori, Sogabe, Koji, Fukui, Kento, Kogure, Masaya, Kishi, Akio, Hata, Shiro, Shinboku, Hiroki, Muroya, Takahiro, Asakura, Masanori, Kitakaze, Masafumi

“…Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the urinary albumin-to-creatinine ratio (UACR) in patients with elevated levels of albuminuria in the…”
Get full text

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design by Fujiki, Shinya, Iijima, Kenichi, Okabe, Masaaki, Niwano, Shinichi, Tsujita, Kenichi, Naito, Shigeto, Ando, Kenji, Kusano, Kengo, Kato, Ritsushi, Nitta, Junichi, Miura, Tetsuji, Mitsuhashi, Takeshi, Kario, Kazuomi, Kondo, Yusuke, Ieda, Masaki, Hagiwara, Nobuhisa, Murohara, Toyoaki, Takahashi, Kazuyoshi, Tomita, Hirofumi, Takeishi, Yasuchika, Anzai, Toshihisa, Shimizu, Wataru, Watanabe, Masafumi, Morino, Yoshihiro, Kato, Takeshi, Tada, Hiroshi, Nakagawa, Yoshihisa, Yano, Masafumi, Maemura, Koji, Kimura, Takeshi, Yoshida, Hisako, Ota, Keiko, Tanaka, Takahiro, Kitamura, Nobutaka, Node, Koichi, Aizawa, Yoshifusa, Shimizu, Ippei, Izumi, Daisuke, Ozaki, Kazuyuki, Minamino, Tohru

“…Introduction Type 2 diabetes (T2DM) is associated with cardiovascular death, including sudden cardiac death due to arrhythmias. Patients with an implantable…”
Get full text

The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL) by Kataoka, Yu, Hosoda, Kiminori, Makino, Hisashi, Matsubara, Masaki, Matsuo, Miki, Ohata, Yoko, Koezuka, Ryo, Tamanaha, Tamiko, Tomita, Tsutomu, Honda-Kohmo, Kyoko, Noguchi, Michio, Son, Cheol, Nishimura, Kunihiro, Asaumi, Yasuhide, Miyamoto, Yoshihiro, Noguchi, Teruo, Yasuda, Satoshi

Get full text

Magneto-transport properties of tellurium under extreme conditions by Akiba, Kazuto, Kobayashi, Kaya, Kobayashi, Tatsuo C, Koezuka, Ryo, Miyake, Atsushi, Gouchi, Jun, Uwatoko, Yoshiya, Tokunaga, Masashi

“…Phys. Rev. B 101, 245111 (2020) This study investigates the transport properties of a chiral elemental semiconductor tellurium (Te) under magnetic fields and…”
Get full text